Charu Aggarwal, MD, MPH

Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
Make an appointmentCall 215-615-5858
Headshot of Charu Aggarwal, MD, MPH
Penn Medicine Provider

About me

  • Physician Leader, Airways Malignancies Research
  • Director, Precision Oncology Innovation, Penn Center for Cancer Care Innovation
  • Section Chief, Head & Neck and Thoracic Cancers, Hematology-Oncology
  • Leslye M. Heisler Professor for Lung Cancer Excellence

Dr. Aggarwal specializes in the management of patients with lung cancer. Her clinical research focus is on the development of novel immunotherapeutic approaches, and the discovery and application of biomarkers to guide therapy and monitor treatment. She serves as the local and national principal investigator for multiple clinical trials focusing on the development of targeted immunotherapy approaches.

My education and training

  • Medical School: Lady Hardinge Medical College
  • Residency: Buffalo General Medical Center
  • Fellowship: Fox Chase Cancer Center

Spoken languages

English
English

Reviews

Average Rating

199 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
my appointment time was 1:30. i was not seen till 3:45 !!! not acceptable. !!!
Anonymous
April 2026
i have already referred my friend
Anonymous
April 2026
my provider really put my worries at ease. she took the time to answer any questions i had and i at no point, felt rushed.
Anonymous
April 2026
my dr is very caring and on top of my cancer care and explains everything

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Aggarwal is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Adam Barsouk, Maxim Yaskolko, Jonathan H. Sussman, Lova Sun, Roger B. Cohen, Charu Aggarwal, Corey J. Langer, Melina E. Marmarelis Sotorasib vs adagrasib in the 2L+ setting: Outcomes in a large, multi-institutional, real-world database of KRAS-G12C mutated mNSCLC. , J Clin Oncol: 2026

Lova Sun, Willdragon Wang, Kyle Chang, Leslie A. Bucheit, Keelia Clemens, Aditi P. Singh, Melina E. Marmarelis, Roger B. Cohen, Corey J. Langer, Charu Aggarwal Long-term ctDNA reassessment (LTctDNA) in NSCLC immunotherapy responders. , J Clin Oncol: 2026

Melina E. Marmarelis, Jessica Dow, Journey Penney, Binyam Yilma, Alexis Aiello, Marina Codari, Chithra Sangli, Karen Huelsman, Andrew J. Parchman, Charu Aggarwal, Sarah G. Thompson, Natraj R. Ammakkanavar, George R. Simon, Amol Rao, Gautum Agarwal, Ezra E. Cohen, Jyoti D. Patel, Noah Zimmerman Multi-center prospective study evaluating an AI-enabled clinical decision support tool to improve biomarker testing in early-stage NSCLC. , J Clin Oncol: 2026

Adam Barsouk, Jonathan H. Sussman, Maxim Yaskolko, Lova Sun, Aditi P. Singh, Charu Aggarwal, Roger B. Cohen, Melina E. Marmarelis, Corey J. Langer Performance status and tarlatamab outcomes in a large, multi-institution real-world database of 2L+ ES-SCLC. , J Clin Oncol: 2026

Teja Voruganti, Yi Lian, Benjamin A. Bleiberg, Lauren Reed-Guy, Roger B. Cohen, David J. Cantor, Kyle W. Robinson, Christopher D'Avella, Christine A. Ciunci, Melina E. Marmarelis, Aditi P. Singh, Corey J. Langer, Lova Sun, Charu Aggarwal SPARK-Lung: A study of patterns and outcomes in young-onset lung cancer , J Clin Oncol: 2026

Klein M, Watson D, Castro M, Kapoor S, Nair PR, Rajagopalan S, Qin H, Glaser M, Westanmo A, Lala DA, Kumar A, Chauhan J, G P, Ullal YS, Kulkarni S, Narvekar Y, Ghosh A, Tyagi A, Patil M, Macpherson MD, Wingrove JA, Patil T, Aggarwal C, Ganti AK. Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint Inhibitors , Clin Lung Cancer: 2026

Phurin Areesawangkit, Adam Barsouk, Maxim Yaskolko, Lucy Wang, Cole Friedes, Roger B. Cohen, Lova Sun, Charu Aggarwal, Melina E. Marmarelis, Aditi P. Singh, Kyle W. Robinson, Christopher D'Avella, Christine A. Ciunci, Steven J. Feigenberg, Jeffrey D. Bradley, Nikhil Yegya-Raman, Michelle Iocolano, Christiana Davis, Corey J. Langer Long-term survival outcomes of consolidative local ablative therapy after response to first-line systemic treatment in oligometastatic NSCLC. , J Clin Oncol: 2026

Michelle A. Worst, Andrew Small, Amy Furedy, Charu Aggarwal, Sandip P. Patel The impact of online CME on addressing clinical decision-making for immunotherapy in advanced squamous NSCLC. , J Clin Oncol: 2026

Xavier Orcutt, Vivek Nimgaonkar, Lova Sun, Charu Aggarwal, Aaron B. Cohen, Ronac Mamtani, Qi Long, Ravi B. Parikh Machine learning risk stratification in a US-based database to identify subgroups of patients with PD-L1-high NSCLC who benefit from adding chemotherapy to pembrolizumab. , J Clin Oncol: 2026

Rachel Jaber Chehayeb, Willdragon Wang, Lova Sun, Aditi P. Singh, Roger B. Cohen, Corey J. Langer, Charu Aggarwal, Melina E. Marmarelis Incidentally discovered lung cancer in explanted lungs at the time of lung transplantation: Management and outcomes. , J Clin Oncol: 2026